subject: UMLS:C0207975

subject_name: Kremezin

object_name: chronic kidney disease


subject: UMLS:C0207975

object_name: Chronic uremia

tested_intervention: yes


subject: UMLS:C5432249


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: focal segmental glomerulosclerosis

tested_intervention: unsure


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C0445115

subject_name: Normal saline

object_name: bronchiolitis


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Myelodysplasia


subject: CHEBI:49005

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:49005

object_name: childhood myelodysplastic syndrome


subject: CHEBI:49005

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:49005

object_name: thalassemia


subject: CHEBI:66910

subject_name: Axitinib

object_name: metastatic malignant neoplasm in the lymph nodes


subject: CHEBI:66910

object_name: Endometrioid carcinoma of prostate


subject: CHEBI:66910

object_name: Adenocarcinoma of the prostate stage III


subject: CHEBI:66910

object_name: Adenocarcinoma of the prostate stage IV


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0728976

object_name: obesity


subject: UMLS:C0728976

object_name: Obesity, CTCAE


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: CHEMBL.COMPOUND:CHEMBL4297251

subject_name: ORANGE JUICE


subject: CHEMBL.COMPOUND:CHEMBL4297251


subject: CHEMBL.COMPOUND:CHEMBL4297251


subject: UMLS:C5702992

subject_name: Voquezna Triple Pak

object_name: Stomach cancer


subject: UMLS:C5702992

object_name: gastric cancer


subject: UMLS:C5702992

object_name: Helicobacter pylori infection


subject: UMLS:C5702992

object_name: gastritis h pylori


subject: UMLS:C1174891

subject_name: Ezetrol

object_name: Drug Interactions


subject: CHEBI:49040

subject_name: Ezetimibe


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: leukopenia


subject: PUBCHEM.COMPOUND:2767

object_name: neutropenia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: UMLS:C4548455

object_name: kidney failure


subject: CHEBI:10127

subject_name: Zonisamide

object_name: focal epilepsy


subject: CHEBI:8346

subject_name: Potassium Iodide

object_name: Pregnant


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: stress related disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:3489

subject_name: Cefmetazole

object_name: colorectal neoplasm


subject: CHEBI:17630

subject_name: Kanamycin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:63610

subject_name: Misoprostol

object_name: previous premature rupture of membranes (history)


subject: CHEBI:63610

object_name: preterm premature rupture of the membranes


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: PUBCHEM.COMPOUND:53477758


subject: PUBCHEM.COMPOUND:53477758


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Low Cardiac Output Syndrome


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:84040

object_name: Diabetes


subject: CHEBI:84040

object_name: diabetes mellitus


subject: CHEBI:84040

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:84040

object_name: obesity


subject: CHEBI:84040

object_name: Obesity, CTCAE


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:27881


subject: PUBCHEM.COMPOUND:71300864

object_name: Reduced ejection fraction co-occurrent and due to chronic heart failure


subject: UMLS:C2933615

subject_name: LCZ 696


subject: DRUGBANK:DB17647

object_name: Danon disease


subject: UMLS:C0338222

subject_name: Tretinoin Liposome

object_name: adult lymphoma


subject: UMLS:C0338222

object_name: lymphoma


subject: UMLS:C0338222

object_name: pediatric lymphoma


subject: CHEBI:144552

subject_name: (R)-oxybutynin

object_name: obstructive sleep apnea syndrome


subject: UMLS:C5783649

subject_name: Aroxybutynin


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: kidney disorder


subject: CHEBI:81579

object_name: impaired renal function disease


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Borderline Resectable Pancreatic Ductal Adenocarcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: UMLS:C1617352

subject_name: INJECTION, PACLITAXEL PROTEIN-BOUND PARTICLES, 1 MG


subject: UMLS:C1617352


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Light for dates


subject: UMLS:C0169964

subject_name: somatropin


subject: PUBCHEM.COMPOUND:6328211

subject_name: Alhydrogel

object_name: hookworm infectious disease


subject: UMLS:C0733770


subject: CHEMBL.COMPOUND:CHEMBL5314986

subject_name: GLA-AF


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: CHEBI:73662

subject_name: Thr-Pro

object_name: Childhood Breast Carcinoma


subject: CHEBI:73662

object_name: breast carcinoma


subject: CHEBI:73662

object_name: breast cancer


subject: PR:000029585

subject_name: lamina-associated polypeptide 2


subject: PR:000029585


subject: PR:000029585


subject: PR:000009721


subject: PR:000009721


subject: PR:000009721


subject: PR:000016875

subject_name: thymidine phosphorylase


subject: PR:000016875


subject: PR:000016875


subject: UMLS:C5444129

subject_name: Latent Membrane Protein 2


subject: UMLS:C5444129


subject: UMLS:C5444129


subject: UMLS:C4687510

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4687510

object_name: cancer


subject: UMLS:C4687510

object_name: neoplasm


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: PUBCHEM.COMPOUND:2767

object_name: thymoma


subject: PUBCHEM.COMPOUND:2767

object_name: thymus neoplasm


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:9014

subject_name: Salsalate

object_name: type 1 diabetes mellitus


subject: CHEBI:9014

object_name: peripheral nervous system disorder


subject: CHEBI:9014

object_name: neuropathy


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Stomach cancer


subject: CHEBI:38940

object_name: gastric cancer


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: Allergic Rhinitis, CTCAE


subject: UMLS:C0910794


subject: UNII:4YO6QT3SZ9

object_name: colorectal cancer


subject: UNII:4YO6QT3SZ9

object_name: colorectal carcinoma


subject: UNII:4YO6QT3SZ9

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:4YO6QT3SZ9

object_name: metastatic colorectal cancer


subject: UNII:4YO6QT3SZ9

object_name: colorectal neoplasm


subject: UNII:4YO6QT3SZ9

object_name: colorectal adenocarcinoma


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: substance-related disorder


subject: CHEBI:166520

object_name: mood disorder


subject: CHEBI:1391

subject_name: Midomafetamine


subject: CHEBI:1391


subject: CHEBI:6887

subject_name: Methylphenidate


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: UMLS:C0879266

subject_name: Autologous Tumor Cell Vaccine

object_name: skin melanoma


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: atrial fibrillation


subject: CHEBI:3160

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:3160

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C5556501

subject_name: IKZF2 Protein Degrader DKY709

object_name: melanoma


subject: UMLS:C5556501

object_name: non-small cell lung carcinoma


subject: UMLS:C5556501

object_name: triple-negative breast carcinoma


subject: UMLS:C5556501

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5556501

object_name: nasopharyngeal carcinoma


subject: UMLS:C5556501

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UNII:CC9149U2QX

subject_name: Sodium ferric gluconate complex

object_name: anemia


subject: UNII:CC9149U2QX

object_name: Anemia, CTCAE


subject: CHEBI:75832

subject_name: ferrous sulfate


subject: CHEBI:75832


subject: CHEBI:3745

subject_name: clindamycin

object_name: anal fistula


subject: CHEBI:90841

subject_name: Cangrelor

object_name: acute coronary syndrome


subject: PUBCHEM.COMPOUND:6912

subject_name: Xylitol

object_name: bacterial infectious disease


subject: CHEBI:17151


subject: UMLS:C4053621

object_name: diffuse large B-cell lymphoma


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Lumbar spondylosis


subject: CHEBI:135983

object_name: Lumbar spondylolisthesis


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: post-traumatic stress disorder


subject: CHEBI:73678

object_name: Chronic uremia


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:42797

subject_name: Gabapentin

object_name: oropharyngeal carcinoma


subject: CHEBI:42797

object_name: oropharynx cancer


subject: MESH:C000707788

subject_name: effervescent calcium magnesium citrate

object_name: end stage renal failure


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: osteoarthritis, knee


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Heart Disease Risk Factors


subject: CHEBI:125628

subject_name: Alisertib

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:125628

object_name: Prostate cancer recurrent


subject: CHEBI:125628

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:125628

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:125628

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:125628

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:125628

object_name: prostate adenocarcinoma


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: CHEBI:2469

subject_name: Adefovir

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol

object_name: Stiffness of unspecified joint, not elsewhere classified


subject: PUBCHEM.COMPOUND:131751561

object_name: Disturbance of activity and attention


subject: PUBCHEM.COMPOUND:131751561

object_name: Arthralgia


subject: PUBCHEM.COMPOUND:131751561

object_name: Arthralgia, CTCAE


subject: PUBCHEM.COMPOUND:131751561

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:131751561

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:131751561

object_name: Good quality of life


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: DRUGBANK:DB14276


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: PUBCHEM.COMPOUND:5281767


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: chronic kidney disease


subject: CHEBI:8228

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: traumatic encephalopathy


subject: CHEBI:39548

object_name: traumatic brain injury


subject: CHEBI:39548

object_name: post-traumatic stress disorder


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: Menopause present (finding)


subject: CHEBI:84094

object_name: Menopause


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:32599

object_name: Cerebral Vasospasm


subject: CHEBI:32599

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: PUBCHEM.COMPOUND:162677492

subject_name: BALIXAFORTIDE

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UNII:PRC974M49B


subject: UMLS:C4550002

subject_name: balixafortide


subject: GTOPDB:13676

subject_name: cosibelimab


subject: UNII:PNW7GBB44P

subject_name: COSIBELIMAB


subject: UMLS:C4726572


subject: UMLS:C5706385

subject_name: EGFR Inhibitor ERAS-801

object_name: IDH-wildtype glioblastoma


subject: UMLS:C5706385

object_name: Resectable Astrocytoma


subject: UMLS:C5706385

object_name: Resectable Glioblastoma


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: short bowel syndrome


subject: UNII:3GBO34D1BE

object_name: systolic heart failure


subject: UMLS:C1330419

subject_name: Niacin ER

object_name: cardiovascular disorder


subject: UMLS:C1330419

object_name: coronary artery disorder


subject: UMLS:C1330419

object_name: peripheral vascular disease


subject: UMLS:C1330419

object_name: peripheral arterial disease


subject: UMLS:C1330419

object_name: diabetes mellitus


subject: CHEBI:135942

subject_name: Laropiprant


subject: CHEBI:135942


subject: CHEBI:135942


subject: CHEBI:135942


subject: CHEBI:135942


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:10216733


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Breastfeeding (mother)


subject: PUBCHEM.COMPOUND:53477758

object_name: Newborn Encounter Admission Source


subject: PUBCHEM.COMPOUND:53477758

object_name: Newborn (finding)


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: CHEBI:2659

subject_name: Aminophylline

object_name: Post-Dural Puncture Headaches


subject: CHEBI:28177

subject_name: Theophylline


subject: UMLS:C1658729

subject_name: CERAVE

object_name: Chronic small plaque psoriasis


subject: UNII:NGB50MQK8N

object_name: atrial fibrillation


subject: UNII:NGB50MQK8N

object_name: Atrial Fibrillation by ECG Finding


subject: UNII:NGB50MQK8N

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C0281549

subject_name: Zenapax

object_name: multiple sclerosis


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Drug Interactions


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:188074


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Childhood Neuroblastoma


subject: UNII:3A58010674

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib


subject: PUBCHEM.COMPOUND:78162481


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: UMLS:C1705207

subject_name: Endostar

object_name: esophageal squamous cell carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Pregnant


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab


subject: UNII:7SQY4ZUD30


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: Prediabetes


subject: CHEBI:49040

object_name: cardiovascular disorder


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: NY-ESO-1 Positive Tumor Cells Present


subject: UNII:M89N0Q7EQR

object_name: Synovial sarcoma recurrent


subject: UNII:M89N0Q7EQR

object_name: HLA-A*0201 Positive Cells Present


subject: UNII:M89N0Q7EQR

object_name: Recurrent Myxoid Liposarcoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C3899995

subject_name: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes


subject: UMLS:C3899995


subject: UMLS:C3899995


subject: UMLS:C3899995


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C3896839

subject_name: Dendritic Cell-targeting Lentiviral Vector ID-LV305


subject: UMLS:C3896839


subject: UMLS:C3896839


subject: UMLS:C3896839


subject: CHEBI:60799

subject_name: Esketamine

object_name: self-limited epilepsy with centrotemporal spikes


subject: CHEBI:27504

subject_name: Mitomycin

object_name: bladder tumor


subject: CHEBI:27504

object_name: urinary bladder carcinoma


subject: CHEBI:27504

object_name: urinary bladder cancer


subject: CHEBI:27504

object_name: childhood bladder carcinoma


subject: CHEBI:27504

object_name: bladder carcinoma in situ


subject: CHEBI:27504

object_name: Stage 0is Bladder Cancer AJCC v8


subject: CHEBI:27504

object_name: papillary carcinoma of bladder


subject: UMLS:C2756587

subject_name: soy

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C2756587

object_name: obesity


subject: UMLS:C2756587

object_name: Obesity, CTCAE


subject: UMLS:C1697820

subject_name: soy - non-drug agent


subject: UMLS:C1697820


subject: UMLS:C1697820


subject: CHEBI:91414

subject_name: Adavosertib

object_name: uterine cancer


subject: CHEBI:91414

object_name: tumor of uterus


subject: UMLS:C4053677


subject: UMLS:C4053677


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:45716

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:45716

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:45716

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:132922

object_name: ulcer disease


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:4975

subject_name: Famotidine


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: Childhood Breast Carcinoma


subject: CHEBI:82677

object_name: breast carcinoma


subject: CHEBI:82677

object_name: breast cancer


subject: CHEBI:82677

object_name: breast neoplasm


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Large vessel vasculitis


subject: CHEBI:31300

object_name: temporal arteritis


subject: CHEBI:31300

object_name: Takayasu arteritis


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:51450


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: neoplasm of chest wall


subject: UNII:P76B05O5V6

subject_name: Relugolix

object_name: uterine fibroid


subject: UNII:P76B05O5V6

object_name: Menorrhagia


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: cardiac allograft vasculopathy


subject: UNII:Y2T4ALDEAT

object_name: acquired polycythemia vera


subject: UNII:Y2T4ALDEAT

object_name: essential thrombocythemia


subject: UNII:Y2T4ALDEAT


subject: UNII:Y2T4ALDEAT

object_name: Post-polycythemia vera myelofibrosis


subject: UNII:Y2T4ALDEAT

object_name: myelofibrosis


subject: UMLS:C0305062

subject_name: Tetanus Toxoid

object_name: meningococcal infection


subject: UMLS:C0305062

object_name: meningitis


subject: UMLS:C0305062

object_name: Meningitis, CTCAE


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Stage IV Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Stage III Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:63791

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:63791

object_name: Marginal zone lymphoma stage III


subject: CHEBI:63791

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:63791

object_name: Marginal zone lymphoma stage IV


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:74708

subject_name: Met-Phe

object_name: asthma


subject: CHEBI:4910

subject_name: Etomidate

object_name: no feeling or sensation of skin


subject: CHEBI:4910

object_name: Sensory Loss


subject: CHEBI:4910

object_name: Increased reactive oxygen species production


subject: CHEBI:24261

subject_name: glucocorticoid

object_name: rheumatoid arthritis


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab

object_name: non-small cell lung carcinoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: metastatic colorectal cancer


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: lung cancer


subject: UNII:M89N0Q7EQR

object_name: lung neoplasm


subject: UNII:M89N0Q7EQR

object_name: lung carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UNII:DPT0O3T46P

object_name: differentiated thyroid carcinoma


subject: UNII:SE2KH7T06F

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:SE2KH7T06F

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:SE2KH7T06F

object_name: Plasma cell myeloma refractory


subject: UNII:SE2KH7T06F

object_name: Advanced Lymphoma


subject: UNII:SE2KH7T06F

object_name: Refractory Lymphoma


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C2826229

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UMLS:C2826229


subject: UNII:AJQ2ZNG2WL

subject_name: Myocet

object_name: Carcinoma breast stage IV


subject: UMLS:C1512062


subject: UMLS:C1815158

subject_name: Flax oil

object_name: bipolar disorder


subject: DRUGBANK:DB11357

subject_name: Linseed oil


subject: CHEBI:9241

subject_name: Spironolactone

object_name: chronic kidney disease


subject: UMLS:C5555143

subject_name: Gallium Ga 68-ICAM-1pep

object_name: cancer


subject: UMLS:C5555143

object_name: neoplasm


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: PUBCHEM.COMPOUND:64987

object_name: Drug problem


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:7465

subject_name: Naltrexone

object_name: heroin dependence


subject: RXCUI:2686972

subject_name: 0.5 ML Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 15A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 16F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 17F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 20A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 23A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 23B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 24F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 31 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 35B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 9N capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype DEOAC15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML Prefilled Syringe

object_name: Immunosuppression


subject: RXCUI:2686972

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C3896738

object_name: acute myeloid leukemia


subject: CHEBI:9932

subject_name: Vancomycin hydrochloride

object_name: dental caries


subject: CHEBI:9932

object_name: Dental Caries, CTCAE


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C0205992

subject_name: vancomycin hydrochloride


subject: UMLS:C0205992


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: secondary hyperparathyroidism


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: UMLS:C3714696

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C3714696


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:177298

object_name: Small cell lung cancer extensive stage


subject: CHEBI:177298

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:177298

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:177298

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:177298

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C0919079

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C0919079

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C0919079

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C5418059

subject_name: AMG 191

object_name: Fanconi anemia


subject: UMLS:C5418059

object_name: Fanconi anemia complementation group A


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:181441

subject_name: (±)-Equol

object_name: Blood Pressure Finding


subject: CHEBI:181441

object_name: Systemic arterial pressure


subject: CHEBI:34741

subject_name: Equol


subject: CHEBI:34741


subject: UMLS:C5392748

object_name: spinal muscular atrophy


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: bacterial pneumonia


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Adult T-cell lymphoma/leukaemia refractory


subject: CHEBI:4026

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:4026

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: UNII:YI437801BE

subject_name: Mogamulizumab


subject: UNII:YI437801BE


subject: UNII:YI437801BE


subject: UNII:YI437801BE


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: UMLS:C1831941


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Estrogen Receptor Positive


subject: CHEBI:49603

object_name: Progesterone Receptor Positive


subject: CHEBI:49603

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:49603

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:49603

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:49603

object_name: HER2 positive breast carcinoma


subject: CHEBI:49603

object_name: Breast cancer recurrent


subject: CHEBI:49603

object_name: HER2/Neu Negative


subject: CHEBI:16908

subject_name: NADH

object_name: Abdominal obesity


subject: CHEBI:15846

subject_name: NAD(+)


subject: CHEBI:13389

subject_name: Nadide


subject: PR:000000291

subject_name: nodal protein isoform 1


subject: PR:000000230

subject_name: cartilage oligomeric matrix protein isoform 1


subject: CHEBI:71219

subject_name: Pazopanib

object_name: glioblastoma


subject: CHEBI:71219

object_name: Brain Stem Glioblastoma


subject: CHEBI:71219

object_name: glioma susceptibility 1


subject: CHEBI:71219

object_name: Childhood Glioblastoma


subject: CHEBI:71219

object_name: adult glioblastoma


subject: CHEBI:71219

object_name: brain cancer


subject: CHEBI:71219

object_name: brain neoplasm


subject: CHEBI:71219

object_name: central nervous system cancer


subject: CHEBI:71219

object_name: Adult Gliosarcoma


subject: CHEBI:71219

object_name: gliosarcoma


subject: CHEBI:71219

object_name: Childhood Gliosarcoma


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:63632


subject: UMLS:C4086231

object_name: cervical polyp


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Critical Illness


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:90001

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:90001

object_name: sarcoma


subject: CHEBI:90001

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:90001

object_name: soft tissue sarcoma


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:114785

subject_name: Erlotinib

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:114785

object_name: tongue cancer


subject: CHEBI:114785

object_name: tongue carcinoma


subject: CHEBI:114785

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:114785

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:114785

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:114785

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:114785

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:114785

object_name: salivary gland squamous cell carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204

object_name: Laryngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Vascular calcification


subject: UNII:1C6V77QF41

object_name: kidney failure


subject: UNII:1C6V77QF41

object_name: End stage renal failure on dialysis


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:191876

object_name: Sepsis


subject: CHEBI:191876

object_name: Sepsis, CTCAE


subject: CHEBI:191876

object_name: mortality


subject: UMLS:C5418043

subject_name: ADC SHR-A1811

object_name: HER2 positive breast carcinoma


subject: UNII:4D28EY0L5T

subject_name: Dasotraline

object_name: Adult attention deficit hyperactivity disorder


subject: PUBCHEM.COMPOUND:577181

subject_name: norsertraline


subject: CHEBI:196955

subject_name: Atogepant

object_name: Episodic migraine


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: pulmonary fibrosis


subject: CHEBI:72690

object_name: Pulmonary Fibrosis, CTCAE


subject: UMLS:C1176324


subject: UMLS:C1176324


subject: CHEBI:31348

subject_name: Capecitabine

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:31348

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:31348

object_name: Stage I Pancreatic Neuroendocrine Tumor AJCC v8


subject: CHEBI:31348

object_name: Stage II Pancreatic Neuroendocrine Tumor AJCC v8


subject: CHEBI:31348

object_name: Stage III Pancreatic Neuroendocrine Tumor AJCC v8


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: Disorder calcium (NOS)


subject: CHEBI:81570

object_name: kidney disorder


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C0309130


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1141639


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: prostate cancer


subject: UMLS:C0013227

object_name: prostate neoplasm


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C2918039

subject_name: Natazia

object_name: Metrorrhagia


subject: UMLS:C2918039

object_name: heavy bleeding between periods (symptom)


subject: UMLS:C0790335

subject_name: Candida albicans skin test antigen

object_name: common wart


subject: UMLS:C0790335

object_name: Human Papilloma Virus, Female


subject: UMLS:C0790335

object_name: Human Papilloma Virus, Male


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Articular disc disorder of temporomandibular joint


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: UMLS:C3273850

subject_name: Indeglitazar

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:163224105

object_name: non-small cell lung carcinoma


subject: UMLS:C5907924

subject_name: EGFR/HER2 Mutant-selective Inhibitor STX-721


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Activating EGFR Gene Mutation


subject: UMLS:C0591327

subject_name: De-capeptyl SR

object_name: precocious puberty


subject: UMLS:C0591327

object_name: Precocious Puberty, CTCAE 5.0


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Post-Operative Pain


subject: UMLS:C1541231

subject_name: GVAX pancreatic cancer vaccine

object_name: pancreatic neoplasm


subject: UMLS:C1541231

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1541231

object_name: malignant pancreatic neoplasm


subject: CHEBI:139019

subject_name: AZD1979 oxetane hydrolysis product

object_name: influenza


subject: CHEBI:175692

subject_name: 4-Hydroxyestrone sulfate


subject: CHEBI:140152

subject_name: cyclosporin A metabolite M1


subject: CHEBI:51079


subject: CHEBI:145218


subject: PUBCHEM.COMPOUND:75053179


subject: CHEBI:165221

subject_name: Desmetramadol


subject: UniProtKB:P15379-3

subject_name: CD44 antigen isoform 12 (mouse)


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: infective endocarditis


subject: UNII:6GNT3Y5LMF

object_name: bacterial endocarditis


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: PUBCHEM.COMPOUND:135512673


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: HMDB:HMDB0015179


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Regional Neuroblastoma


subject: UNII:M89N0Q7EQR

object_name: Neuroblastoma recurrent


subject: UNII:M89N0Q7EQR

object_name: Disseminated neuroblastoma


subject: UNII:M89N0Q7EQR

object_name: Stage 4S neuroblastoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:6067

subject_name: Isotretinoin


subject: UNII:7SQY4ZUD30

subject_name: Dinutuximab


subject: UNII:7SQY4ZUD30


subject: UNII:7SQY4ZUD30


subject: UNII:7SQY4ZUD30


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: preeclampsia


subject: CHEBI:46195

object_name: preeclampsia/eclampsia 1


subject: CHEBI:46195

object_name: hypertension, pregnancy-induced


subject: CHEBI:46195

object_name: HELLP syndrome


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: GTOPDB:9704

subject_name: isunakinra

object_name: Adult Solid Neoplasm


subject: UNII:5QM1ZK6VXZ

subject_name: ISUNAKINRA


subject: UMLS:C4519727

subject_name: Isunakinra


subject: CHEBI:74705

subject_name: Met-Leu

object_name: epidermolysis bullosa dystrophica


subject: CHEBI:74705

object_name: Wound healed (finding)


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:17621

subject_name: FMN

object_name: keratoconus


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Pancreatic cancer non-resectable


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UMLS:C5847498

subject_name: Irinotecan liposome injection

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C5847498


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:3XVL385Q0M

subject_name: Filgotinib

object_name: cutaneous lupus erythematosus


subject: UNII:A6U64OU57E

subject_name: Lanraplenib


subject: UMLS:C1971564

subject_name: Injection, levetiracetam, 10 mg administered

object_name: Neonatal seizure


subject: UMLS:C1971564

object_name: Neonatal encephalopathy


subject: UMLS:C1971564

object_name: perinatal asphyxia


subject: UMLS:C1971564

object_name: Neonatal hypoxic and ischemic brain injury


subject: UMLS:C1971564

object_name: Hypoxic-Ischemic Encephalopathy


subject: UMLS:C1971564

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: UMLS:C5203562

subject_name: Levetiracetam Liquid Injection


subject: UMLS:C5203562


subject: UMLS:C5203562


subject: UMLS:C5203562


subject: UMLS:C5203562


subject: UMLS:C5203562


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: PUBCHEM.COMPOUND:156963690

subject_name: Somapacitan

object_name: Congenital IGHD


subject: PUBCHEM.COMPOUND:156963690

object_name: Reduced circulating growth hormone concentration


subject: PUBCHEM.COMPOUND:156963690

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:156963690

object_name: maturity-onset diabetes of the young type 1


subject: PUBCHEM.COMPOUND:156963690

object_name: neoplasm


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: psoriatic arthritis


subject: CHEBI:195559

subject_name: Poziotinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:195559

object_name: breast carcinoma


subject: CHEBI:195559

object_name: breast cancer


subject: GTOPDB:13627

subject_name: zanidatamab

object_name: biliary tract cancer


subject: GTOPDB:13627

object_name: liver carcinoma


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB


subject: UNII:Z20OC92TDI


subject: UMLS:C4331966


subject: UMLS:C4331966


subject: CHEBI:65173

subject_name: Iloperidone

object_name: Uncontrolled hypertension


subject: CHEBI:65173

object_name: hypertension


subject: CHEBI:65173

object_name: Hypertension, CTCAE


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib


subject: CHEBI:35553

subject_name: Perhexiline

object_name: Myocardial Reperfusion Injury


subject: CHEBI:35553

object_name: Decreased cardiac output


subject: CHEBI:134344

subject_name: Thioredoxins

object_name: end stage renal failure


subject: CHEBI:134344

object_name: Chronic uremia


subject: CHEBI:134344

object_name: kidney failure


subject: CHEBI:4828

subject_name: Ergothioneine


subject: CHEBI:4828


subject: CHEBI:4828


subject: CHEBI:50634

object_name: Headache


subject: CHEBI:50634

object_name: Headache, CTCAE


subject: CHEBI:50634

object_name: migraine


subject: CHEBI:50634

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: PUBCHEM.COMPOUND:444033

subject_name: Ciclesonide

object_name: Allergy


subject: PUBCHEM.COMPOUND:444033

object_name: History of allergies


subject: PUBCHEM.COMPOUND:425400

subject_name: alpha-Tocopherol succinate

object_name: tetralogy of fallot


subject: CHEBI:230570


subject: CHEBI:22470

subject_name: alpha-tocopherol


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEMBL.COMPOUND:CHEMBL2108252

subject_name: APOLIZUMAB

object_name: B-cell chronic lymphocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: mantle cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: diffuse large B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108252

object_name: follicular lymphoma


subject: UMLS:C1120775

subject_name: Hu1D 10


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: UMLS:C1120775


subject: CHEBI:28364

subject_name: Icosapent

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:24956525

subject_name: Tyrosine kinase inhibitor


subject: UMLS:C1268567

subject_name: Protein-tyrosine kinase inhibitor


subject: CHEBI:230905

subject_name: Ribociclib

object_name: Advanced breast cancer


subject: CHEBI:87681

subject_name: Ranolazine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:87681

object_name: amyotrophic lateral sclerosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Disorder of knee


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Arthritis of knee


subject: CHEBI:4466

object_name: knee pain chronic


subject: CHEBI:4466

object_name: osteoarthritis, knee


subject: CHEBI:4466


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Sepsis


subject: CHEBI:50275

object_name: Sepsis, CTCAE


subject: CHEBI:50275

object_name: septic shock


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Clear cell tumor


subject: UNII:DPT0O3T46P

object_name: female reproductive organ cancer


subject: PUBCHEM.COMPOUND:3663

subject_name: hypericin

object_name: psoriasis


subject: PUBCHEM.COMPOUND:3663

object_name: Chronic small plaque psoriasis


subject: PUBCHEM.COMPOUND:3663

object_name: psoriasis vulgaris


subject: CHEBI:5835

subject_name: Hypericin


subject: CHEBI:5835


subject: CHEBI:5835


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: chronic disease


subject: CHEBI:38290

object_name: Chronic Disease


subject: CHEBI:38290

object_name: acute disease


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C4522080


subject: CHEBI:63631

subject_name: Topiramate

object_name: Androgen excess


subject: CHEBI:132922

object_name: Hernia


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:6121

subject_name: Ketamine

object_name: Depression and Suicide


subject: CHEBI:6121

object_name: Severe depression


subject: CHEBI:4670

subject_name: Dobutamine

object_name: Mitral valve stenosis with incompetence or regurgitation


subject: UNII:349552KRHK

subject_name: Simendan


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:7824

subject_name: Oxcarbazepine

object_name: trigeminal neuralgia


subject: UMLS:C3539963

subject_name: Amide local anesthetic combinations

object_name: colorectal cancer


subject: UMLS:C3539963

object_name: colorectal carcinoma


subject: UMLS:C3539963

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3539976

subject_name: Penicillins with extended spectrum combinations


subject: UMLS:C3539976


subject: UMLS:C3539976


subject: UMLS:C3540719


subject: UMLS:C3540719


subject: UMLS:C3540719


subject: UMLS:C3539181

subject_name: Short-acting sulfonamide combinations


subject: UMLS:C3539181


subject: UMLS:C3539181


subject: UMLS:C3540722

subject_name: Beta-lactamase sensitive penicillin combinations


subject: UMLS:C3540722


subject: UMLS:C3540722


subject: UMLS:C3539959

subject_name: Long-acting sulfonamide combinations


subject: UMLS:C3539959


subject: UMLS:C3539959


subject: UMLS:C3539969

subject_name: Specific immunoglobulin combinations


subject: UMLS:C3539969


subject: UMLS:C3539969


subject: UMLS:C3540031

subject_name: gonadotropin combinations


subject: UMLS:C3540031


subject: UMLS:C3540031


subject: UMLS:C3540026

subject_name: Hepatitis vaccine combinations


subject: UMLS:C3540026


subject: UMLS:C3540026


subject: UMLS:C3539182

subject_name: Salt solution combinations


subject: UMLS:C3539182


subject: UMLS:C3539182


subject: UMLS:C3539955

subject_name: lung surfactant combinations


subject: UMLS:C3539955


subject: UMLS:C3539955


subject: UMLS:C3539956

subject_name: Magnesium antacid compound combinations


subject: UMLS:C3539956


subject: UMLS:C3539956


subject: UMLS:C3539957

subject_name: opium alkaloids and derivative combination cough suppressants


subject: UMLS:C3539957


subject: UMLS:C3539957


subject: UMLS:C3539960

subject_name: Other intestinal adsorbent combinations in ATC


subject: UMLS:C3539960


subject: UMLS:C3539960


subject: UMLS:C3539961

subject_name: Platelet aggregation inhibitor combinations excl. heparin


subject: UMLS:C3539961


subject: UMLS:C3539961


subject: UMLS:C3539962

subject_name: vitamin D and analog combinations


subject: UMLS:C3539962


subject: UMLS:C3539962


subject: UMLS:C3539964

subject_name: local opthalmologic anesthetic combinations


subject: UMLS:C3539964


subject: UMLS:C3539964


subject: UMLS:C3539965

subject_name: Local hemostatic combinations


subject: UMLS:C3539965


subject: UMLS:C3539965


subject: UMLS:C3539966

subject_name: insulins and analogs for injection combinations, long-acting


subject: UMLS:C3539966


subject: UMLS:C3539966


subject: UMLS:C3539967

subject_name: Insulins and analogs for injection, intermediate-acting combined with fast-acting- combinations


subject: UMLS:C3539967


subject: UMLS:C3539967


subject: UMLS:C3539968

subject_name: Enema combinations


subject: UMLS:C3539968


subject: UMLS:C3539968


subject: UMLS:C3539970

subject_name: combination drugs used in erectile dysfunction


subject: UMLS:C3539970


subject: UMLS:C3539970


subject: UMLS:C3539971

subject_name: otologic analgesic and anesthetic combinations


subject: UMLS:C3539971


subject: UMLS:C3539971


subject: UMLS:C3539972

subject_name: Combination solutions for parenteral nutrition


subject: UMLS:C3539972


subject: UMLS:C3539972


subject: UMLS:C3539973

subject_name: Other antifungal combinations for topical use in ATC


subject: UMLS:C3539973


subject: UMLS:C3539973


subject: UMLS:C3539974

subject_name: Insulins and analogs for injection, intermediate-acting combinations


subject: UMLS:C3539974


subject: UMLS:C3539974


subject: UMLS:C3539975

subject_name: Aluminium antacid compound combinations


subject: UMLS:C3539975


subject: UMLS:C3539975


subject: UMLS:C3539977

subject_name: Calcium antacid compound combinations


subject: UMLS:C3539977


subject: UMLS:C3539977


subject: UMLS:C3539978

subject_name: expectorant combinations excluding combinations with cough suppressants


subject: UMLS:C3539978


subject: UMLS:C3539978


subject: UMLS:C3539979

subject_name: Antiinfective irrigating solution combinations


subject: UMLS:C3539979


subject: UMLS:C3539979


subject: UMLS:C3540027

subject_name: Adrenergic and dopaminergic agents combinations


subject: UMLS:C3540027


subject: UMLS:C3540027


subject: UMLS:C3540028

subject_name: Other irrigating solution combinations in ATC


subject: UMLS:C3540028


subject: UMLS:C3540028


subject: UMLS:C3540030

subject_name: other cough suppressant combinations in ATC


subject: UMLS:C3540030


subject: UMLS:C3540030


subject: UMLS:C3540720

subject_name: Caries prophylactic agent combinations


subject: UMLS:C3540720


subject: UMLS:C3540720


subject: UMLS:C3540721

subject_name: other nasal preparation combinations in ATC


subject: UMLS:C3540721


subject: UMLS:C3540721


subject: UMLS:C3540723

subject_name: Insulins and analogs for injection, fast-acting combinations


subject: UMLS:C3540723


subject: UMLS:C3540723


subject: UMLS:C3540724

subject_name: expectorant combinations, excl. combinations with cough suppressants


subject: UMLS:C3540724


subject: UMLS:C3540724


subject: UMLS:C3854036

subject_name: Other anti-dementia drug combinations in ATC


subject: UMLS:C3854036


subject: UMLS:C3854036


subject: UNII:0MFM55849I

subject_name: MAGALDRATE

object_name: Heartburn


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: hypertension


subject: PUBCHEM.COMPOUND:73151030

object_name: Hypertension, CTCAE


subject: CHEBI:74705

subject_name: Met-Leu

object_name: keratitis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:90881

subject_name: Camptosar

object_name: male breast carcinoma


subject: CHEBI:90881

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:90881

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:90881

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:90881

object_name: Breast cancer recurrent


subject: CHEBI:90881

object_name: CNS metastases


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:65346

subject_name: Aclidinium

object_name: COPD, severe early onset


subject: UNII:S9J80L3D1U

subject_name: PELAREOREP

object_name: Childhood Breast Carcinoma


subject: UNII:S9J80L3D1U

object_name: breast carcinoma


subject: UNII:S9J80L3D1U

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: metastatic melanoma


subject: UMLS:C2346454


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:87620

subject_name: EPIESTRIOL

object_name: Menopause present (finding)


subject: CHEBI:87620

object_name: Menopause


subject: CHEBI:27974

subject_name: Estriol


subject: CHEBI:27974


subject: PUBCHEM.COMPOUND:165437864

object_name: intermittent explosive disorder


subject: UNII:372X2P22UY


subject: CHEBI:36796

subject_name: duloxetine

object_name: Diabetic peripheral neuropathic pain


subject: CHEBI:36796

object_name: generalized anxiety disorder


subject: MESH:C502407

object_name: major depressive disorder


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: DiGeorge syndrome


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab


subject: UMLS:C0281549

subject_name: Zenapax


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C1871143

subject_name: apilimod mesylate

object_name: Crohn disease


subject: CHEBI:9168

subject_name: Sirolimus

object_name: mild neurocognitive disorder


subject: CHEBI:33942

subject_name: ribose

object_name: Presenile dementia


subject: CHEBI:33942

object_name: dementia


subject: CHEBI:47013

subject_name: D-ribofuranose


subject: CHEBI:47013


subject: CHEBI:16988

subject_name: D-ribose


subject: CHEBI:16988


subject: UMLS:C4547412

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: HER2 positive breast carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:176724

subject_name: Etiracetam

object_name: bipolar disorder


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:32696

object_name: MELAS syndrome


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: anemia


subject: CHEBI:38290

object_name: Anemia, CTCAE


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:76607

subject_name: Macitentan

object_name: chronic thromboembolic pulmonary hypertension


subject: CHEBI:6121

subject_name: Ketamine

object_name: hip fracture


subject: UMLS:C5783010

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5783010

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C5783010

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEBI:5801

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: autoimmune thrombocytopenia


subject: CHEBI:3732

subject_name: Clarithromycin


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:J2Q5XQZ64C

object_name: psoriasis


subject: CHEBI:4975

subject_name: Famotidine


subject: UMLS:C0021734

subject_name: Roferon-A


subject: CHEBI:177387

subject_name: Brequinar


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Malignant Solid Neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UMLS:C1384659

object_name: pancreatic neoplasm


subject: UMLS:C1384659

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1384659

object_name: malignant pancreatic neoplasm


subject: UMLS:C1384659

object_name: biliary tract cancer


subject: UMLS:C1384659


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:52172

subject_name: Nilotinib

object_name: tenosynovial giant cell tumor


subject: CHEBI:52172

object_name: tenosynovial giant cell tumor, diffuse type


subject: UMLS:C1177020

subject_name: Mobilan

object_name: prostate carcinoma


subject: UMLS:C1177020

object_name: prostate cancer


subject: UMLS:C4329277

subject_name: Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3


subject: UMLS:C4329277


subject: UMLS:C1505595

object_name: Advanced cancer


subject: UMLS:C1505595

object_name: Solid Neoplasm


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:53074

subject_name: Diphencyprone

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:53074

object_name: vitiligo


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: lung cancer


subject: CHEBI:6888

object_name: lung neoplasm


subject: CHEBI:6888

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Muscle spasm


subject: PUBCHEM.COMPOUND:4715169

object_name: Muscle Cramp, CTCAE


subject: PUBCHEM.COMPOUND:4715169

object_name: liver cirrhosis


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:23359

subject_name: colchicine

object_name: Overweight and obesity


subject: MESH:C029449

subject_name: polyene phosphatidylcholine

object_name: chronic hepatitis B virus infection


subject: MESH:C029449

object_name: hepatitis B


subject: UMLS:C0359953

subject_name: bupivacaine / epinephrine

object_name: arthritis


subject: UMLS:C0359953

object_name: Arthritis, CTCAE


subject: UMLS:C0359953

object_name: arthropathy


subject: UMLS:C0359953

object_name: osteoarthritis


subject: UMLS:C0359953

object_name: Arthrosis


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: pulmonary hypertension, primary, 1


subject: PUBCHEM.COMPOUND:131769963

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:131769963

object_name: idiopathic pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:131769963

object_name: pulmonary arterial hypertension


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:89584422

subject_name: Larotinib

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:89584422

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:89584422

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:89584422

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:89584422

object_name: neoplasm of esophagus


subject: UMLS:C5418059

subject_name: AMG 191

object_name: severe combined immunodeficiency


subject: CHEBI:9907

subject_name: ursodiol

object_name: gestational diabetes


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: medulloblastoma


subject: UMLS:C2830069

object_name: childhood medulloblastoma


subject: UMLS:C2830069

object_name: adult medulloblastoma


subject: UMLS:C2830069

object_name: Childhood Neuroblastoma


subject: UMLS:C2830069

object_name: neuroblastoma


subject: UMLS:C2830069

object_name: hepatoblastoma


subject: UMLS:C2830069

object_name: liver carcinoma


subject: UMLS:C2830069

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C2830069

object_name: rhabdomyosarcoma


subject: UMLS:C2830069

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C2830069

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C2830069

object_name: Childhood Astrocytoma


subject: UMLS:C2830069

object_name: glioma susceptibility 1


subject: UMLS:C2830069

object_name: astrocytic tumor


subject: UMLS:C2830069

object_name: astrocytoma


subject: UMLS:C2830069

object_name: glioma


subject: UMLS:C2830069

object_name: malignant glioma


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: AIDS


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: UMLS:C4287586

subject_name: Ceftazidime/Avibactam Sodium

object_name: Complicated intra-abdominal infection


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:47657

subject_name: Roflumilast

object_name: ulcerative colitis


subject: CHEBI:47657

object_name: inflammatory bowel disease 1


subject: CHEBI:68554

subject_name: Deferiprone

object_name: sickle cell disease


subject: CHEBI:68554

object_name: other anemia


subject: UMLS:C1533391

subject_name: collagen, hydrolyzed

object_name: osteoporosis


subject: UMLS:C1533391

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C1533391

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C1533391

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C0445115

subject_name: Normal saline

object_name: stroke disorder


subject: UMLS:C0445115

object_name: cerebrovascular disorder


subject: UMLS:C0445115

object_name: Stroke (heart beat)


subject: UMLS:C0445115

object_name: Stroke, CTCAE


subject: MESH:D000077331

subject_name: Ringer's Solution


subject: MESH:D000077331


subject: MESH:D000077331


subject: MESH:D000077331


subject: CHEBI:189666


subject: CHEBI:189668

subject_name: Varespladib


subject: PR:000004089

subject_name: aldehyde oxidase

object_name: mild neurocognitive disorder


subject: PR:000004089

object_name: mild cognitive impairment


subject: PR:000004089

object_name: Alzheimer disease type 1


subject: PR:000004089

object_name: Alzheimer disease


subject: PR:000022129

subject_name: acetylornithine deacetylase


subject: PR:000022129


subject: PR:000022129


subject: PR:000022129


subject: GTOPDB:8088

subject_name: epratuzumab

object_name: childhood malignant neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108404

subject_name: EPRATUZUMAB


subject: UMLS:C0281743


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:31824

subject_name: Mesna

object_name: leukemia


subject: CHEBI:31824

object_name: childhood leukemia


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: multiple sclerosis


subject: CHEBI:18248

subject_name: Iron

object_name: Iron poor blood


subject: CHEBI:18248

object_name: Knee arthropathy


subject: CHEBI:18248

object_name: Hip arthropathy


subject: CHEBI:18248

object_name: musculoskeletal system disorder


subject: CHEBI:29034

subject_name: Ferric cation


subject: CHEBI:29034


subject: CHEBI:29034


subject: CHEBI:29034


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:176838

subject_name: vitamin B2

object_name: anemia


subject: CHEBI:176838

object_name: Anemia, CTCAE


subject: CHEBI:176838


subject: CHEBI:176838


subject: CHEBI:176838


subject: CHEBI:176838


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: UMLS:C5387587

subject_name: coronavirus vaccine


subject: CHEBI:4305

subject_name: dacarbazine

object_name: malignant soft tissue neoplasm


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: infertility


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: malignant epithelioid mesothelioma


subject: PUBCHEM.COMPOUND:2767

object_name: Mesothelioma malignant recurrent


subject: PUBCHEM.COMPOUND:2767

object_name: sarcomatoid mesothelioma


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: GTOPDB:7986

subject_name: rilotumumab


subject: GTOPDB:7986

object_name: malignant mesothelioma


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UMLS:C1879711

subject_name: AMG 102


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: PUBCHEM.COMPOUND:381525

subject_name: beta-L-Dioxolane-cytidine

object_name: acute myeloid leukemia


subject: CHEBI:134886

subject_name: Troxacitabine


subject: UNII:SJ5A8151JO

object_name: severe COVID-19


subject: UMLS:C3500968

object_name: type 2 diabetes mellitus


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:64312

object_name: Skin-picking


subject: CHEBI:36796

subject_name: duloxetine

object_name: Urinary incontinence


subject: CHEBI:36796

object_name: Urinary Incontinence, CTCAE 5.0


subject: UMLS:C5222411

subject_name: Butorphanol Tartrate Liquid Injection

object_name: pain agnosia


subject: UMLS:C5222411

object_name: Pain insensitivity


subject: UMLS:C2974798

object_name: Postoperative cognitive dysfunction


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR


subject: GTOPDB:11827

subject_name: telitacicept

object_name: myasthenia gravis


subject: GTOPDB:11827

object_name: Myasthenia Gravis, CTCAE


subject: GTOPDB:11827

object_name: Autoimmunity


subject: CHEMBL.COMPOUND:CHEMBL5095293

subject_name: TELITACICEPT


subject: CHEMBL.COMPOUND:CHEMBL5095293


subject: CHEMBL.COMPOUND:CHEMBL5095293


subject: UMLS:C5238006


subject: UMLS:C5238006


subject: UMLS:C5238006


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: nasopharyngeal carcinoma


subject: UNII:5S371K6132

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:3638

subject_name: Chloroquine

object_name: Brain Stem Glioblastoma


subject: CHEBI:3638

object_name: glioma susceptibility 1


subject: CHEBI:15365

subject_name: Aspirin

object_name: breast neoplasm


subject: CHEBI:37941

subject_name: Clopidogrel


subject: CHEBI:28364

subject_name: Icosapent

object_name: Malignant cachexia


subject: CHEBI:35523

subject_name: bronchodilator agent

object_name: asthma


subject: UMLS:C0006280

subject_name: Bronchodilator Agents


subject: CHEBI:231601

subject_name: trastuzumab

object_name: lung cancer


subject: CHEBI:231601

object_name: lung neoplasm


subject: CHEBI:231601

object_name: lung carcinoma


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:90841

subject_name: Cangrelor

object_name: arteriosclerosis disorder


subject: CHEBI:90841

object_name: atherosclerosis


subject: UNII:EUL6MP8FZW

subject_name: AMRUBICIN HYDROCHLORIDE


subject: UNII:EUL6MP8FZW


subject: UNII:EUL6MP8FZW


subject: UMLS:C1706799

subject_name: amrubicin hydrochloride


subject: UMLS:C1706799


subject: UMLS:C1706799


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: liver carcinoma


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: UMLS:C0962969

subject_name: RAD 001


subject: CHEBI:27470

subject_name: Folic acid

object_name: malaria


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:177298

object_name: non-small cell lung carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: retinopathy of prematurity


subject: UNII:15C2VL427D

object_name: exudative vitreoretinopathy 1


subject: UNII:15C2VL427D

object_name: Retinopathy of Prematurity, AE


subject: UMLS:C0721963

subject_name: Nasacort AQ

object_name: perennial allergic rhinitis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: polycystic liver disease 1


subject: PUBCHEM.COMPOUND:70789204

object_name: autosomal dominant polycystic liver disease


subject: CHEBI:91899

object_name: congenital alveolar dysplasia


subject: CHEBI:91899

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:91899

object_name: adult acute respiratory distress syndrome


subject: CHEBI:91899

object_name: newborn respiratory distress syndrome


subject: CHEBI:91899

object_name: bronchopulmonary dysplasia


subject: CHEBI:91899

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:91899

object_name: Premature infant


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:3207


subject: CHEBI:3207


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: recessive dystrophic epidermolysis bullosa


subject: UNII:789Q85GA8P

subject_name: Vorasidenib

object_name: glioma


subject: UNII:789Q85GA8P

object_name: malignant glioma


subject: UMLS:C2981842

object_name: Weight loss


subject: UMLS:C2981842

object_name: Weight Loss, CTCAE


subject: UMLS:C2981842

object_name: pancreatic neoplasm


subject: UMLS:C2981842

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2981842

object_name: malignant pancreatic neoplasm


subject: UMLS:C2981842

object_name: Cachexia


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: DRUGBANK:DB18158

object_name: Angelman syndrome


subject: PUBCHEM.COMPOUND:66555030

subject_name: Oliceridine

object_name: Hypoventilation


subject: PUBCHEM.COMPOUND:66555030

object_name: Adverse drug response


subject: PUBCHEM.COMPOUND:66555030

object_name: Burn injury


subject: PUBCHEM.COMPOUND:66555030

object_name: post operative nausea and vomiting


subject: UNII:C37E62Z9JZ

subject_name: ALBUMIN HUMAN, RECOMBINANT

object_name: mumps


subject: UNII:C37E62Z9JZ

object_name: measles


subject: UNII:C37E62Z9JZ

object_name: chickenpox


subject: UMLS:C2713349

subject_name: Nebido

object_name: hypogonadism


subject: CHEBI:94187

subject_name: Givinostat

object_name: Duchenne muscular dystrophy


subject: CHEBI:2038

subject_name: Azacitidine

object_name: Neck Carcinoma


subject: CHEBI:2038

object_name: head and neck neoplasm


subject: CHEBI:2038

object_name: head and neck cancer


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: UNII:64FS3BFH5W

subject_name: EPOETIN

object_name: chronic kidney disease


subject: UNII:64FS3BFH5W

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:64FS3BFH5W

object_name: anemia


subject: UNII:64FS3BFH5W

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: UMLS:C0014822

subject_name: Erythropoietin


subject: UMLS:C0014822


subject: UMLS:C0014822


subject: UMLS:C0014822


subject: UNII:69VKY8P7EA

object_name: endometrial cancer


subject: UNII:69VKY8P7EA

object_name: uterine corpus cancer


subject: UNII:69VKY8P7EA

object_name: endometrial carcinoma


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C2004126


subject: UMLS:C2004126


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C0281549

subject_name: Zenapax


subject: PUBCHEM.COMPOUND:135618605

subject_name: poly If

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:135618605

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:192

subject_name: Adenosine diphosphate ribose


subject: PUBCHEM.COMPOUND:192


subject: PUBCHEM.COMPOUND:30243

subject_name: ADP ribose


subject: PUBCHEM.COMPOUND:30243


subject: CHEBI:16960

subject_name: ADP-D-ribose


subject: CHEBI:16960


subject: UMLS:C5552697

subject_name: Membrane Attack Complex


subject: UMLS:C0009545

subject_name: Complement Membrane Attack Complex


subject: CHEBI:33330

subject_name: scandium atom

object_name: inflammatory bowel disease 1


subject: CHEBI:33330

object_name: Crohn disease


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: PUBCHEM.COMPOUND:435949


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: UMLS:C4284724

subject_name: Allele-Specific Oligonucleotide

object_name: Bacterial keratitis


subject: UMLS:C4284724

object_name: bacterial infectious disease


subject: UMLS:C4284724

object_name: eye disorder


subject: UMLS:C4284724

object_name: Sensation Disorders


subject: UMLS:C4284724

object_name: corneal disease


subject: UMLS:C4284724

object_name: vision disorder


subject: UMLS:C4284724

object_name: blindness


subject: UMLS:C0003436

subject_name: Antistreptolysin O


subject: UMLS:C0003436


subject: UMLS:C0003436


subject: UMLS:C0003436


subject: UMLS:C0003436


subject: UMLS:C0003436


subject: UMLS:C0003436


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: cervical cancer


subject: CHEBI:175901

object_name: cervical carcinoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: thrombotic microangiopathy


subject: CHEBI:28939

object_name: hematologic disorder


subject: UNII:Q830PW7520

subject_name: CODEINE

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: Musculoskeletal Pain


subject: CHEBI:35475

object_name: Acute Pain


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: CHEBI:135285

subject_name: Vildagliptin

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:135565341

subject_name: Dersalazine sodium

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:135565341

object_name: inflammatory bowel disease 1


subject: UNII:BAB844203H

subject_name: DERSALAZINE SODIUM


subject: UNII:BAB844203H


subject: UMLS:C3826869

subject_name: SOM230 LAR

object_name: polycystic liver disease 1


subject: UMLS:C3826869

object_name: autosomal dominant polycystic liver disease


subject: UMLS:C3826869

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:231683

subject_name: Anakinra

object_name: immune system disorder


subject: CHEBI:231683

object_name: Autoimmune connective tissue disorder


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: CHEBI:75012

subject_name: Val-Ile

object_name: COPD, severe early onset


subject: CHEBI:75012

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0082559

subject_name: Feiba

object_name: heart disorder


subject: PUBCHEM.COMPOUND:2723635

subject_name: GLUCOSAMINE HYDROCHLORIDE

object_name: lichen planus, oral


subject: CHEBI:20993

subject_name: GLUCOSAMINE


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: AIDS dementia


subject: CHEBI:63925

subject_name: PhXa 85

object_name: exfoliation syndrome


subject: CHEBI:39465

subject_name: timolol


subject: PUBCHEM.COMPOUND:135565609

subject_name: Hetrombopag olamine

object_name: autoimmune thrombocytopenia


subject: UMLS:C5418132

subject_name: Hetrombopag Olamine


subject: CHEBI:32599

object_name: persistent fetal circulation syndrome


subject: UMLS:C0003195

subject_name: Anti-Arrhythmia Agents

object_name: ventricular tachycardia


subject: UMLS:C0003195

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: UMLS:C0003195

object_name: continuous electrocardiogram ventricular tachycardia


subject: UMLS:C0003195

object_name: Ventricular Tachycardia by ECG Finding


subject: UMLS:C0003195

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: MESH:D010919

subject_name: Placebos

object_name: atopic eczema


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Pregnant


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: GTOPDB:13613

subject_name: lumasiran

object_name: Hyperoxaluria


subject: UNII:RZT8C352O1

subject_name: Lumasiran


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: secondary hyperparathyroidism


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:2549

subject_name: Albuterol

object_name: congenital myopathy


subject: CHEBI:2549

object_name: nemaline myopathy


subject: CHEBI:2549

object_name: MYH7-related skeletal myopathy


subject: CHEBI:2549

object_name: hyaline body myopathy


subject: CHEBI:2549

object_name: congenital myopathy 7A, myosin storage, autosomal dominant


subject: CHEBI:2549

object_name: centronuclear myopathy


subject: CHEBI:2549

object_name: congenital structural myopathy


subject: CHEBI:2549

object_name: musculoskeletal system disorder


subject: CHEBI:2549

object_name: neuromuscular disease


subject: UMLS:C4757537

subject_name: Albuterol only product in oral dose form


subject: UMLS:C4757537


subject: UMLS:C4757537


subject: UMLS:C4757537


subject: UMLS:C4757537


subject: UMLS:C4757537


subject: UMLS:C4757537


subject: UMLS:C4757537


subject: UMLS:C4757537


subject: UMLS:C1506837

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:63587

subject_name: Eribulin


subject: UMLS:C3827093

subject_name: Autologous Tumor Cell Proteoliposome Chronic Lymphocytic Leukemia Vaccine

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:HX101E7L6S

subject_name: oregovomab

object_name: fallopian tube carcinoma


subject: UNII:HX101E7L6S

object_name: fallopian tube cancer


subject: UMLS:C0664206

subject_name: Ovarex


subject: UMLS:C0664206


subject: UMLS:C5959095

subject_name: EGFR Mutant-selective Inhibitor TRX-221

object_name: non-small cell lung carcinoma


subject: CHEBI:50138

subject_name: Lonidamine

object_name: benign prostatic hyperplasia


subject: CHEBI:50138

object_name: Large prostate


subject: DRUGBANK:DB17107

subject_name: Lifileucel

object_name: Metastatic Uveal Melanoma


subject: DRUGBANK:DB17107

object_name: Metastatic Cutaneous Melanoma


subject: PR:000001151

subject_name: Toll-like receptor 1


subject: PR:000001151


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: primary adrenal insufficiency


subject: CHEBI:27470

subject_name: Folic acid

object_name: Live Birth


subject: CHEBI:27470

object_name: Pregnant


subject: CHEBI:27470

object_name: Miscarriage


subject: CHEBI:27470

object_name: spontaneous abortion


subject: UMLS:C4521070

object_name: Nonulcer dyspepsia


subject: UMLS:C1384659

object_name: carcinoma of the ampulla of vater


subject: UMLS:C1384659

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UMLS:C1384659

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UMLS:C1384659

object_name: gallbladder cancer


subject: UMLS:C1384659

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UMLS:C1384659

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UMLS:C1384659

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UMLS:C1384659

object_name: gallbladder carcinoma


subject: UMLS:C1384659

object_name: liver carcinoma


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEBI:49960


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER

object_name: acute respiratory distress syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108465

object_name: adult acute respiratory distress syndrome


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:C5529G5JPQ


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Lymphoma, Extranodal NK-T-Cell


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Distal Radius Fractures


subject: CHEBI:60802

object_name: Fractured scaphoid bone


subject: CHEBI:60802

object_name: WRIST INJURY ARTHRODESIS


subject: CHEBI:44915

subject_name: Propofol

object_name: Decreased liver function


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:135390844

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:135390844

object_name: prostate cancer


subject: UMLS:C5237263

subject_name: Gallium Ga 68-PSMA-617


subject: UMLS:C5237263


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Carcinoma of peritoneum


subject: CHEBI:7457

subject_name: Nalmefene

object_name: alcohol abuse


subject: CHEBI:7457

object_name: alcohol dependence


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: systemic sclerosis


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Nonmetastatic Castration-Resistant Prostate Carcinoma


subject: CHEBI:90881

subject_name: Camptosar

object_name: Childhood Breast Carcinoma


subject: CHEBI:90881

object_name: breast carcinoma


subject: CHEBI:90881

object_name: breast cancer


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C5960055

subject_name: Efimosfermin Alfa

object_name: metabolic dysfunction-associated steatotic liver disease


subject: PUBCHEM.COMPOUND:23594367

subject_name: Boceprevir

object_name: Liver Cirrhosis, Experimental


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:33704

subject_name: Amino acid

object_name: Paresis


subject: CHEBI:33704

object_name: Muscle weakness


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UMLS:C0002520


subject: UMLS:C2917660

subject_name: Amino Acid [EPC]


subject: UMLS:C2917660


subject: PUBCHEM.COMPOUND:71300864

object_name: essential hypertension


subject: CHEBI:16493

subject_name: 1-Deoxy-D-xylulose 5-phosphate

object_name: Post-Operative Pain


subject: UMLS:C2603422

object_name: diabetic retinopathy


subject: UMLS:C2603422

object_name: diabetes mellitus


subject: UNII:21K6M2I7AG

subject_name: interferon gamma-1b

object_name: retinal disease


subject: UNII:21K6M2I7AG

object_name: Abnormal macular morphology


subject: UMLS:C0021741

subject_name: Actimmune


subject: UMLS:C0021741


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Stage IV Esophageal Squamous Cell Carcinoma AJCC v7


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: focal segmental glomerulosclerosis


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C1879771

subject_name: BIBF 1120

object_name: urothelial carcinoma


subject: UMLS:C1879771

object_name: transitional cell carcinoma


subject: CHEBI:85164

subject_name: Nintedanib


subject: CHEBI:85164


subject: CHEBI:30360

subject_name: tert-pentyl group


subject: CHEBI:6504

object_name: brain cancer


subject: CHEBI:6504

object_name: brain neoplasm


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:45716

object_name: Carcinoma breast stage IV


subject: CHEBI:45716

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:45716

object_name: male breast carcinoma


subject: CHEBI:45716

object_name: Breast cancer recurrent


subject: UMLS:C3896901

object_name: breast neoplasm


subject: CHEBI:50730

subject_name: Montelukast

object_name: Exercise-induced asthma


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: heart valve disorder


subject: CHEBI:68579

object_name: Valvular Heart Disease, CTCAE


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:10033


subject: CHEBI:63631

subject_name: Topiramate

object_name: HIV infection


subject: CHEBI:63631

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:18375622

subject_name: MART-1 Antigen

object_name: uveal melanoma


subject: PUBCHEM.COMPOUND:18375622

object_name: iris melanoma


subject: PUBCHEM.COMPOUND:18375622

object_name: medium/large size posterior uveal melanoma


subject: PUBCHEM.COMPOUND:18375622

object_name: ocular melanoma with extraocular extension


subject: UMLS:C3146272

subject_name: MART-1 Antigen (vaccine component)


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C0281722

subject_name: gp100 Antigen

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C0281722

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0281722

object_name: metastatic melanoma


subject: UMLS:C0281722

object_name: stage IIC melanoma


subject: UMLS:C0281722

object_name: Stage IIB Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0281722

object_name: stage IIB melanoma


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22

object_name: stage IIIB melanoma


subject: UNII:5TAA004E22

object_name: stage IIIC melanoma


subject: UNII:5TAA004E22

object_name: stage IIIA melanoma


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0338254

subject_name: tyrosinase peptide


subject: UMLS:C0338254


subject: UMLS:C0338254


subject: UMLS:C0338254


subject: UMLS:C0338254


subject: UMLS:C0338254


subject: UMLS:C0338254


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: Coronavinae infectious disease


subject: UNII:VHC779598X

subject_name: Capravirine


subject: CHEBI:6121

subject_name: Ketamine

object_name: Chronic Daily Headache


subject: CHEBI:6121

object_name: headache disorder


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: cardiovascular disorder


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:75283

subject_name: Miltefosine

object_name: leishmaniasis


subject: UMLS:C5854362

subject_name: Anti-PD-L1/Anti-VEGF Bispecific Antibody Fusion Protein B1962

object_name: cancer


subject: UMLS:C5854362

object_name: nervous system cancer


subject: UMLS:C0287374

object_name: irritable bowel syndrome


subject: CHEBI:82339

subject_name: Merphalan

object_name: melanoma


subject: CHEBI:82339

object_name: skin melanoma


subject: CHEBI:82339

object_name: ocular melanoma


subject: CHEBI:82339

object_name: uveal melanoma


subject: CHEBI:82339

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:61000

subject_name: erythrosin B

object_name: thyroid; functional disturbance


subject: UNII:1A878FZQ9B

subject_name: Erythrosine


subject: CHEBI:24859

subject_name: iodine atom


subject: CHEBI:17606

subject_name: Iodine


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: CHEBI:135207

subject_name: Clofedanol

object_name: coronary artery disorder


subject: CHEBI:135207

object_name: coronary atherosclerosis


subject: CHEBI:8774

subject_name: Ramipril


subject: CHEBI:8774


subject: CHEBI:50223

subject_name: Dexrazoxane

object_name: congenital heart disease


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Non-small cell lung cancer stage I


subject: UMLS:C3827082


subject: UMLS:C4310138

object_name: atopic eczema


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Advanced Melanoma


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Unresectable Melanoma


subject: CHEBI:75045

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:75045

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Melanoma recurrent


subject: UMLS:C2346820


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: cutaneous leishmaniasis


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:73611

subject_name: Met-Gly

object_name: juvenile neuronal ceroid lipofuscinosis


subject: CHEBI:73611

object_name: neuronal ceroid lipofuscinosis 3


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: diastolic heart failure


subject: CHEBI:51450

subject_name: Bosentan


subject: PR:000014047

subject_name: eosinophil cationic protein

object_name: Cutaneous T-cell lymphoma, unspecified


subject: PR:000014047

object_name: Chronic graft versus host disease in skin


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:35677

subject_name: Betahistine

object_name: vestibular disorder


subject: CHEBI:35677

object_name: inner ear disorder


subject: CHEBI:35677

object_name: Vestibular Disorder, CTCAE


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: Small cell lung cancer extensive stage


subject: UNII:15C2VL427D

object_name: Small cell lung cancer recurrent


subject: UMLS:C0218184

subject_name: Kogenate

object_name: hemophilia A


subject: UMLS:C0961271


subject: CHEBI:70839

subject_name: Dasatinib

object_name: childhood malignant neoplasm


subject: CHEBI:70839

object_name: Frailty


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:57694


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:16243


subject: CHEBI:42567

subject_name: Fisetin


subject: CHEBI:42567


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Prediabetes


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution

object_name: Hip arthropathy


subject: UMLS:C5782829

object_name: osteoarthritis, hip


subject: UMLS:C5782829

object_name: hip pain chronic


subject: UNII:C3VX249T6L

subject_name: Ravulizumab


subject: UNII:C3VX249T6L

object_name: acute kidney failure


subject: UNII:C3VX249T6L

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Chronic liver disease


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa


subject: CHEBI:81579

subject_name: Erythropoietin


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: cholangiocarcinoma


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: MESH:C000710692

object_name: Alzheimer disease


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: septic shock


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Adult Penile Carcinoma


subject: CHEBI:45863

object_name: penis carcinoma


subject: CHEBI:45863

object_name: penile cancer


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: cardiovascular disorder


subject: PUBCHEM.COMPOUND:66580799

subject_name: Roginolisib

object_name: Metastatic Uveal Melanoma


subject: UNII:6K8FC2TF54

subject_name: ROGINOLISIB


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Stage IV Prostate Cancer AJCC v8


subject: UNII:4T36H88UA7

object_name: Stage IVA Prostate Cancer AJCC v8


subject: UNII:4T36H88UA7

object_name: Prostate Carcinoma Metastatic in the Bone


subject: CHEBI:8382

subject_name: Prednisone

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:8382


subject: CHEBI:8382


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone